Related Experiment Video
Updated: Jun 30, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Impact of conotruncal anomalies on outcomes following total cavopulmonary connection
Soi Avgeridou1,2,3, Muneaki Matsubara1,2,3,4, Ruxandra Dumitru1,2,3
1Department of Congenital and Pediatric Heart Surgery, TUM University Hospital, German Heart Centre, Munich, Germany.
Insights
Conotruncal anomalies do not impact long-term outcomes after total cavopulmonary connection. Dominant right ventricular morphology is the key factor in Fontan failure and tachyarrhythmia, not the specific diagnosis.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Congenital Heart Disease
Background:
- Long-term outcomes after total cavopulmonary connection (TCPC) are crucial for patients with complex congenital heart disease.
- The influence of conotruncal anomalies and dominant ventricular morphology on these outcomes requires further clarification.
Purpose of the Study:
- To investigate the independent impact of conotruncal anomalies on long-term outcomes after TCPC.
- To determine the role of dominant ventricular morphology versus specific diagnoses in predicting outcomes.
Main Methods:
- Retrospective review of 650 patients undergoing TCPC between 1994-2023.
- Analysis of transplant-free survival, Fontan failure, tachyarrhythmia, and ventricular dysfunction.
- Multivariable Cox regression and propensity weighting to assess conotruncal anomaly and ventricular morphology effects.
Main Results:
- Conotruncal anomalies were present in 44.8% of patients; no difference in survival or Fontan failure was observed.
- Dominant right ventricular morphology was independently linked to higher rates of Fontan failure and tachyarrhythmia.
- Hemodynamic parameters and exercise capacity did not differ between groups; outcomes clustered by morphology, not diagnosis.
Conclusions:
- Conotruncal anomalies do not independently predict adverse outcomes post-TCPC.
- Dominant right ventricular morphology is the primary determinant of long-term Fontan outcomes, surpassing diagnostic category.
Objectives:
The impact of conotruncal anomalies on long-term outcomes after total cavopulmonary connection remains unclear, particularly regarding haemodynamic performance and dominant ventricular morphology.
Methods:
All patients who underwent total cavopulmonary connection between 1994 and 2023 at a single centre were reviewed. Conotruncal anomalies were defined as transposition of the great arteries, double outlet right ventricle, tetralogy of Fallot, truncus arteriosus, and interrupted aortic arch type B. Four endpoints were analysed: transplant-free survival, Fontan failure, tachyarrhythmia, and ventricular dysfunction. Multivariable Cox regression, inverse probability of treatment weighting, and subgroup analyses were performed to disentangle conotruncal anomaly effects from dominant ventricular morphology.
Results:
Among the 650 patients, 291 (44.8%) were identified with conotruncal anomalies. During a median follow-up of 6.3 years, no differences were observed in transplant-free survival (log-rank p = 0.136) or Fontan failure (p = 0.717) between groups. Dominant right ventricular morphology was independently associated with Fontan failure (hazard ratio: 2.20; p = 0.006) and tachyarrhythmia (hazard ratio: 3.22; p = 0.004). These findings were confirmed across all sensitivity analyses. No differences were detected in filling pressures, cardiac index, or peak oxygen uptake on post-operative catheterisation (n = 226) and cardiopulmonary exercise testing (n = 161). When stratified into four groups by conotruncal status and dominant ventricular morphology, freedom from Fontan failure clustered by morphology rather than diagnostic category (4-way log-rank p < 0.001).
Conclusions:
Conotruncal anomalies are not independently associated with adverse outcomes following total cavopulmonary connection. Dominant right ventricular morphology, not diagnostic category, is the principal determinant of long-term Fontan outcomes.
Related Concept Videos
Pneumothorax II: Pathophysiology
Mitral Stenosis I: Introduction
Atelectasis II: Pathophysiology
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Mitral Valve Prolapse II: Assessment and Management

